{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-045249","form_type":"8-K/A","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2023-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.591816+00:00","generated_at":"2026-06-10T09:02:48.310082+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Dorothy J. Clarke appointed to all three committees of Eterna Therapeutics Board","bullets":["Dorothy J. Clarke appointed to Audit Committee, Compensation Committee, and Nominating and Governance Committee.","Appointment effective September 23, 2023; committee roles are immediate.","Clarke joined the Board on August 28, 2023, for term through 2024 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-045249","json":"https://secwatch.observer/filing/0001140361-23-045249.json","markdown":"https://secwatch.observer/filing/0001140361-23-045249.md","text":"https://secwatch.observer/filing/0001140361-23-045249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036123045249/0001140361-23-045249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036123045249/ef20011289_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:02:48.310082+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}